Rocky Mountain Cancer Center-Midtown — Denver, Colorado

Rocky Mountain Cancer Center-Midtown is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center-Midtown has participated in 9 clinical trials.

Therapeutic areas: Ovarian Cancer, Prostate Cancer, Breast Cancer.

Sponsors: Unither Pharmaceuticals, US Oncology Research, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center-Midtown?

Rocky Mountain Cancer Center-Midtown has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center-Midtown conducted?

Rocky Mountain Cancer Center-Midtown has 9 clinical trials on record. Their work covers Ovarian Cancer, Prostate Cancer, Breast Cancer.

Is Rocky Mountain Cancer Center-Midtown accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Center-Midtown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Center-Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.